# Tacrolimus for Thrombocytopenia in SS

> **NCT05678335** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Peking Union Medical College Hospital** · enrollment: 54 (estimated)

## Conditions studied

- Sjogren Syndrome With Other Organ Involvement

## Interventions

- **DRUG:** Hydroxychloroquine
- **DRUG:** Tacrolimus

## Key facts

- **NCT ID:** NCT05678335
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-02
- **Primary completion:** 2023-12
- **Final completion:** 2024-03
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2023-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05678335

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05678335, "Tacrolimus for Thrombocytopenia in SS". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05678335. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*